Fatigue is common to all the rheumatic conditions, in varying degrees, and is a frequent,
often severe problem that has major consequences on patients' lives (1–4). In response to …

Chronic fatigue is a common, poorly understood and disabling phenomenon in many
diseases. We aim to provide an overview of fatigue in chronic autoimmune and inflammatory …

Objective: A study was undertaken to test the psychometric properties of the Fatigue Severity
Scale (FSS), and to explore the relationship between fatigue and sociodemographic …

Multiple sclerosis (MS) is an immune mediated disease of the central nervous system (CNS)
and the leading cause of non-traumatic disability among young and middle-aged adults in …

Background Type I interferons (IFN-I) contribute to a broad range of rheumatic and
musculoskeletal diseases (RMDs). Compelling evidence suggests that the measurement of …

Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease with a
prevalence of approximately 1 in 1000. Over the last 30 years, advances in treatment such …

Objective To examine the frequency and reliability of depression, fatigue, and pain self‐
report measures in patients with systemic lupus erythematosus (SLE) and healthy controls …

Objective Fatigue is reported in up to 90% of patients with SLE. This study was conducted to
identify the determinants associated with fatigue in a large cohort of patients with SLE, as …

Objective Obesity induces a proinflammatory state and is a major cause of morbidity in the
general population. However, little is known about the effects of obesity in patients with …

Systemic lupus erythematosus is a chronic inflammatory autoimmune disease often
characterized by fatigue, with significant effects on physical functioning and wellbeing. The …